24 May 2013
Keywords: roberts, agrelin, nda, accepted, usa, pharmaceutical, new
Article | 25 March 1996
Roberts Pharmaceutical's New Drug Application for Agrelin (anagrelide),
an antiplatelet drug for the treatment of thrombocytosis, has been
accepted by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 June 1996
23 May 2013
© 2013 thepharmaletter.com